Teladoc Health, Inc. (LON:0LDR)
London flag London · Delayed Price · Currency is GBP · Price in USD
5.36
-0.18 (-3.34%)
At close: Mar 20, 2026

Teladoc Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,5302,5702,6022,4072,033
Revenue Growth (YoY)
-1.54%-1.26%8.13%18.41%85.81%
Cost of Revenue
771.59751.27760.03743.99650.26
Gross Profit
1,7581,8181,8421,6631,382
Selling, General & Admin
1,2801,3461,3671,3011,105
Depreciation & Amortization Expenses
364.08373.55337.07256.03204.24
Research & Development
277.92307.27348.52333.63311.88
Other Operating Expenses
99.56812.138.0513,42626.64
Operating Income
-262.96-1,021-248.55-13,653-265.63
Interest Income
36.7757.0746.7812.670.78
Interest Expense
-19.71-23.8-22.28-21.94-81.14
Other Non-Operating Income (Expense)
10.37-6.044.45-0.86-38.66
Total Non-Operating Income (Expense)
27.4327.2328.95-10.13-119.03
Pretax Income
-235.53-993.65-219.61-13,663-384.66
Provision for Income Taxes
-35.217.590.76-3.8144.14
Net Income
-200.32-1,001-220.37-13,660-428.79
Net Income to Common
-200.32-1,001-220.37-13,660-428.79
Shares Outstanding (Basic)
176171165161157
Shares Outstanding (Diluted)
176171165161157
Shares Change (YoY)
3.32%3.64%1.93%2.88%73.40%
EPS (Basic)
-1.14-5.87-1.34-84.60-2.73
EPS (Diluted)
-1.14-5.87-1.34-84.60-2.73
Free Cash Flow
285.46282.89338.56172.81185.46
Free Cash Flow Growth
0.91%-16.44%95.91%-6.82%-
Free Cash Flow Per Share
1.621.662.061.071.18
Gross Margin
69.50%70.76%70.80%69.09%68.01%
Operating Margin
-10.39%-39.73%-9.55%-567.27%-13.07%
Profit Margin
-7.92%-38.97%-8.47%-567.53%-21.09%
FCF Margin
11.28%11.01%13.01%7.18%9.12%
EBITDA
113.48-638.04100.17-13,385-46.11
EBITDA Margin
4.49%-24.83%3.85%-556.14%-2.27%
EBIT
-262.96-1,021-248.55-13,653-265.63
EBIT Margin
-10.39%-39.73%-9.55%-567.27%-13.07%
Effective Tax Rate
14.95%-0.76%-0.35%0.03%-11.47%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.